ES421751A1 - Procedimiento para la preparacion de derivados de piperazi-na racemicos u opticamente activos. - Google Patents

Procedimiento para la preparacion de derivados de piperazi-na racemicos u opticamente activos.

Info

Publication number
ES421751A1
ES421751A1 ES421751A ES421751A ES421751A1 ES 421751 A1 ES421751 A1 ES 421751A1 ES 421751 A ES421751 A ES 421751A ES 421751 A ES421751 A ES 421751A ES 421751 A1 ES421751 A1 ES 421751A1
Authority
ES
Spain
Prior art keywords
carbon atoms
alkyl
angle
hydrogen
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES421751A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of ES421751A1 publication Critical patent/ES421751A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES421751A 1972-12-23 1973-12-22 Procedimiento para la preparacion de derivados de piperazi-na racemicos u opticamente activos. Expired ES421751A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2263211A DE2263211A1 (de) 1972-12-23 1972-12-23 Neue arylpiperazine und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES421751A1 true ES421751A1 (es) 1976-12-16

Family

ID=5865328

Family Applications (10)

Application Number Title Priority Date Filing Date
ES421751A Expired ES421751A1 (es) 1972-12-23 1973-12-22 Procedimiento para la preparacion de derivados de piperazi-na racemicos u opticamente activos.
ES444731A Expired ES444731A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444732A Expired ES444732A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444738A Expired ES444738A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444736A Expired ES444736A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444730A Expired ES444730A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444733A Expired ES444733A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444735A Expired ES444735A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444737A Expired ES444737A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444734A Expired ES444734A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.

Family Applications After (9)

Application Number Title Priority Date Filing Date
ES444731A Expired ES444731A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444732A Expired ES444732A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444738A Expired ES444738A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444736A Expired ES444736A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444730A Expired ES444730A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444733A Expired ES444733A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444735A Expired ES444735A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444737A Expired ES444737A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES444734A Expired ES444734A1 (es) 1972-12-23 1976-01-29 Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.

Country Status (15)

Country Link
US (1) US3941789A (es)
JP (4) JPS4994688A (es)
AT (1) AT338271B (es)
BE (1) BE809041A (es)
CH (10) CH605872A5 (es)
DE (1) DE2263211A1 (es)
ES (10) ES421751A1 (es)
FI (1) FI59990C (es)
FR (1) FR2211252B1 (es)
GB (1) GB1456253A (es)
IE (1) IE38679B1 (es)
LU (1) LU69064A1 (es)
NL (1) NL7317469A (es)
NO (1) NO140381C (es)
SE (1) SE417516B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075335A (en) * 1972-08-24 1978-02-21 Ciba-Geigy Corporation Pharmaceutical piperidine derivatives
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
US4100282A (en) * 1972-12-23 1978-07-11 Boehringer Ingelheim Gmbh N-Aryl-N'-(phenyl- or phenoxy-alkyl)-piperazines and salts thereof
US4440774A (en) * 1975-03-03 1984-04-03 Merck & Co., Inc. 3-Amino-2-hydroxypropoxyaryl imidazole derivatives
GB1518559A (en) * 1976-04-12 1978-07-19 Science Union & Cie Naphthyl derivatives processes for their preparation an pharmaceutical compositions containing them
US4052399A (en) * 1976-09-13 1977-10-04 Morton-Norwich Products, Inc. 1-[2-(Hexahydro-1H-azepino)ethyl]-2(1H)pyrimidone dihydrochloride
US4052400A (en) * 1976-10-29 1977-10-04 Morton-Norwich Products, Inc. Hypertensive 1-substituted 2(1h)-pyrimidones
EP0005828B1 (de) * 1978-06-06 1981-03-11 Hoechst Aktiengesellschaft Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
DE2834114A1 (de) * 1978-08-01 1980-02-14 Schering Ag Polyalkoxyphenylpyrrolidone iii, verfahren zu ihrer herstellung und ihre verwendung
DE3005287A1 (de) * 1980-02-13 1981-08-20 Basf Ag, 6700 Ludwigshafen Phenylpiperazinderivate von 1,3,4-oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel
DE3101502A1 (de) * 1981-01-19 1982-08-26 Basf Ag, 6700 Ludwigshafen Phenylpiperazinderivate von hetarylphenolen und hetarylanilinen, ihre hersttellung und diese enthaltendetherapeutische mittel
DE3101456A1 (de) 1981-01-19 1982-09-02 Basf Ag, 6700 Ludwigshafen Phenylpiperazinyl-propanole von hetarylphenolen, ihre herstellung und diese enthaltende therapeutische mittel
CH653021A5 (fr) * 1981-04-24 1985-12-13 Delalande Sa Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant.
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4450272A (en) * 1982-05-06 1984-05-22 American Cyanamid Company Antiatherosclerotic 1-piperazine-thicarboxamides
US4452798A (en) * 1982-06-22 1984-06-05 Warner-Lambert Company 1-Substituted phenyl-4-alkyl hydantoin piperazine compounds as antihypertensive agents
EP0138754B1 (de) * 1983-08-15 1988-05-25 Ciba-Geigy Ag Photohärtbare Gemische
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4539318A (en) * 1984-06-04 1985-09-03 Merck & Co., Inc. Tertiary aminohydroxypropoxy substituted thiadiazoles, pharmaceutical compositions and use
US4616017A (en) * 1984-06-04 1986-10-07 Merck & Co., Inc. Aminohydroxypropoxy substituted aryl compounds
DE3424685A1 (de) * 1984-07-05 1986-02-06 Beiersdorf Ag, 2000 Hamburg Neue substituierte phenylpiperazinyl-propanole, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
US4732895A (en) * 1986-05-02 1988-03-22 American Cyanamid Company α-[5-methyl-2-(pyridinyl)-1H-imidazol-4-yl]substituted-1-piperazineethanols useful for treating hypertension
US4931443A (en) * 1986-10-27 1990-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Piperazine compound and pharmaceutical use thereof
DE3803860A1 (de) * 1988-02-09 1989-08-17 Basf Ag N,n'-disubstituierte piperazine
US5382583A (en) * 1989-04-22 1995-01-17 John Wyeth & Brother, Limited Piperazine derivatives
US5364849A (en) * 1989-04-22 1994-11-15 John Wyeth & Brother, Limited 1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
US5166148A (en) * 1990-07-09 1992-11-24 The Du Pont Merck Pharmaceutical Company 2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
WO1994018172A1 (en) * 1993-02-01 1994-08-18 Yoshitomi Pharmaceutical Industries, Ltd. Imidazolylbenzene compound and use thereof as medicine
IL114027A (en) * 1994-06-08 1999-11-30 Lundbeck & Co As H 4-Phenyl piperazine (piperidine or tetrahydropyridine) derivatives serotinin 5-HT1A and dopamin D2 receptor ligand pharmaceutical compositions containing them
JP3948744B2 (ja) * 1994-11-04 2007-07-25 大日本住友製薬株式会社 新規なラクタム誘導体
ATE340173T1 (de) * 1996-03-29 2006-10-15 Duphar Int Res Piperazin- und piperidin- derivate
JP4349320B2 (ja) 2005-05-12 2009-10-21 パナソニック株式会社 マニピュレータ型ロボット
AU2006308167A1 (en) 2005-10-27 2007-05-03 Ucb Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
US10126380B2 (en) * 2015-06-15 2018-11-13 Norell, Inc. Closure and system for NMR sample containers with a secondary locking seal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL274491A (es) * 1961-02-08
US3562277A (en) * 1967-09-06 1971-02-09 Shulton Inc Ketonic derivatives of phenyl piperazines
BE788280A (fr) * 1971-09-04 1973-02-28 Pfizer Nouvelles 1-(3-trifluoro-methyl-phenyl)-4-((amido cyclique)- alkyl) piperazines et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
CH616670A5 (es) 1980-04-15
ES444737A1 (es) 1977-05-16
NO140381B (no) 1979-05-14
NO140381C (no) 1979-08-22
CH616676A5 (es) 1980-04-15
AT338271B (de) 1977-08-10
CH616673A5 (es) 1980-04-15
JPS5976070A (ja) 1984-04-28
US3941789A (en) 1976-03-02
ES444738A1 (es) 1977-05-16
IE38679L (en) 1974-06-23
CH616674A5 (es) 1980-04-15
ES444730A1 (es) 1977-05-16
FI59990C (fi) 1981-11-10
JPS4994688A (es) 1974-09-09
IE38679B1 (en) 1978-05-10
JPS5976074A (ja) 1984-04-28
AU6397773A (en) 1975-07-03
NL7317469A (es) 1974-06-25
CH616677A5 (es) 1980-04-15
CH616669A5 (es) 1980-04-15
DE2263211A1 (de) 1974-07-04
CH616668A5 (es) 1980-04-15
CH605872A5 (es) 1978-10-13
CH616667A5 (es) 1980-04-15
BE809041A (fr) 1974-06-21
FI59990B (fi) 1981-07-31
GB1456253A (en) 1976-11-24
FR2211252A1 (es) 1974-07-19
ES444736A1 (es) 1977-05-16
ES444733A1 (es) 1977-05-16
ES444735A1 (es) 1977-05-16
FR2211252B1 (es) 1977-01-28
LU69064A1 (es) 1975-08-20
ES444732A1 (es) 1977-05-16
ES444731A1 (es) 1977-05-16
ES444734A1 (es) 1977-05-16
SE417516B (sv) 1981-03-23
ATA1072773A (de) 1976-12-15
CH616675A5 (es) 1980-04-15
JPS5976067A (ja) 1984-04-28

Similar Documents

Publication Publication Date Title
ES444735A1 (es) Procedimiento para la preparacion de derivados de piperazinaracemicos u opticamente activos.
ES459348A1 (es) Procedimiento para preparar compuestos tetraciclicos.
MY102518A (en) Substituted bridged-diazabicycloalkyl quinolone carboxylic acids
GB1331405A (en) Esters their production and their medicinal use
ES425786A1 (es) Procedimiento para la preparacion de nuevas indolil-piperi-dino-(o 1,2,5,6-tetrahidro-piridil)-butirofenonas.
ES417862A1 (es) Un procedimiento para preparar nuevos derivados de pipera- zina.
ES482700A1 (es) Procedimiento para la obtencion de alfa-azolil-beta-hidroxi-cetonas.
ES8502688A1 (es) Procedimiento para preparar derivados de quinolina
DK120483D0 (da) Phenylpiperazinderivater og fremgangsmade til deres fremstilling
ES438571A1 (es) Metodo de producir compuestos de bencilidensimicarbazida.
EP0089765A3 (en) Pyridine derivatives
ES476166A1 (es) Procedimiento para la preparacion de nuevas imidazo-isoqui- nolein-dionas
ES472276A1 (es) Un procedimiento para la preparacion de un grupo de cis-4a- aril-octahidro-1h-2-pirindinas 2-sustituidas
ES8705392A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidroisoquinolina.
ES416614A1 (es) Procedimiento de preparacion de (benzoil-2et-1'-il)-1-(ci- namil-4''-piperazin-1''-il-metil)-2-bencimidazoles.
ES424346A1 (es) Procedimiento para la preparacion de nuevas imidazo (1,2-a)s-triazinas.
SE7905051L (sv) Nya sulfonamider
ES408603A1 (es) Procedimiento para la preparacion de compuestos tricicli- cos.
ES419044A1 (es) Procedimiento para preparar nuevos derivados del 1,4-benzo-dioxano.
ES433957A1 (es) Un procedimiento de preparacion de nuevas fenotiazinas.
ES395586A1 (es) Procedimiento para la preparacion de aminocetonas.
ES441437A1 (es) Procedimiento para la preparacion de crotonanilidas susti- tuidas.
ES405281A1 (es) Un procedimiento para preparar nuevos compuestos de cefa- losporina.
GB1501588A (en) 4,5-disubstituted 2-oxazolealkanoic acids esters and alkali metal salts
GB1065684A (en) Pseudo-oxatriazoles

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19850227